Recombinant tissue-type plasminogen activator: An infarct-sparing effect beyond thrombolysis?  by Kloner, Robert A. & Eisenhauer, Andrew
226 
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There is on question that ‘_.z!;. :aranary artery rcpertus~on 
will reduce myocardizl in:zrct six (II. lo eiperimer.tal 
canine preparations a pertnanen~ (without reperfusion) prox- 
imal coronary artery occlusion will result in an infarct that is 
nearly transmural and occupies a large proportion of the 
ischemtc nsk zone. Imcrmpting the coronary occlusion with 
reperfusion will reduce infarct size BS long as reperfusion 
occttrs within about 3 h of ischemia (1.2). Inherent in the 
concept that thrombolytic therapy for acute myocardial 
infarction will better palienl outcome is the conrrpt that 
early reperfusion will limit myocardial infarct size. How- 
ever, there may be other modes by which thrombolytic 
agents improve outcome (3!. One is by reducing the devel- 
opment of myocardial infarct expansion and Possibly by 
reducing arrhythmias 13.4). 
The present study. The report hy Egarhiraet al. (51 in this 
issue of the Icurnal suggests that the thrombolytic ageot 
recombinant tissue-type plasminqen activator (rt-PA) may 
have beneficial effects on the myocardial infarct in addition 
to its ability to lyse proximal coronary thrombi. The inves- 
tigators compared myocardial infarct size sod r:ardiac func- 
tion in ancslhetized closed chest dogs subjected to coronary 
artery occlusion induced by thrombus (copper coil tcch- 
aique) or by mechanical occlusion with an intracoronary 
balloon. They made the potentially impotiant observation 
that for equal durattons of ischemia, repelfusion with rt-TA 
in the thrombus model resulted in a smaller infarct and better 
left ventricular function than d!d reperfusion achieved by 
deflating the introcoronary ba!loon. Although the investiga- 
tors (5) concluded that “rt-PA could salvage the ischemic 
myocardium through mechanisms other than lysis of coro- 
nary thrombus,” our opinion is that this conclusion. how- 
ever intriguing, should he interpreted with caution. 
There are potential technical differences between group 1 
W-PA Infusion at 90 min) and group IV (balloon catheter 
rcperfusion) that may help to explain the investigators’ 
results. The introduction of a 2F Fogarty catheter in the 
closed chest dog model required the use of B guiding cathe- 
ter. lntubation of the left main coronary anery with the 
guiding catheter may diminish left coronmv blood Row in the 
diagonal system p&imal to the inflation site even before 
balloon inflation. In addilion, duringthe time that the balloon 
was inflated, continued coronary instrumentation proximal 
to the balloon site may have created additional ischemia and 
reduced “artery to artery” local collateral flow beWee” the 
proximal diagonal distribution ard the target ischemic terr- 
tory. No group was subjected to permanent mechanical 
occ!uwn <by !eaving the ballnon inflatedl. Therefore, it is 
not oossible to determine whether a nonlvsed thrombus 
occI&~on (group 1111 would have caused a different size 
infarct from that induced by a nonreperfused balloon occlu- 
sion. It is also not known to what extent infarct size was 
reduced by detiating the balloon in this study, in comparison 
with the infarct size induced by a permanent coronary 
occlusion achieved by balloon inflation. The thrombus 
model may have resulted in distal emboli. Administration of 
rt.PA may have lysed these emboli, thus contributing to the 
smaller infarct size compared with that observed in the 
mechanical occlusion-repetfusion group. It was not do-x- 
mented that owe intracoronary thrombi were created they 
remained conrinuossly totally occlusive for the subsequent 
90 min. Spontaneour reperfusion and reocclusioo can occur. 
Periods of reperfusion might have reduced ultimate infarct 
size in the lhrombus model compared with that in the 
mechanical model. Furthermore. the thrombus group was 
protected against secondary thrombus formation by contin- 
uous infusion of n-PA over the subrequent 24 h. The balloon 
occlusion group was not. and coronary patency at 24 h WBE 
not documented. These considerations may have led to a 
larger infarc: size in the mechanical balloon occlusion- 
reperfusion group IV compared with that in group I. 
As the investigators have pointed wt. mvocardial blood 
Row was not measured in their study. Thus. it is not clear 
that the degree of ischemia ws equal among the groups. 
There is no question that the determinants of myocanlial 
infarct size in the canine model are the duration of ischemia. 
the size of the risk zone and the degree of coronary collat- 
ered blood Row within the nsk zone 16). Reduction of infarct 
size in the canine model may be assessed by plotting areas of 
necrosis as a percent of risk zone versus coronary collateral 
flow. Typically this results in an inverse lioear relation and 
infarct-sparing drugs will shift the relation between these 
variables downward. That is. for any given collateral flow, 
infarct size will be smaller in a treatment group. 
Role OF rt-PA in reducing ir?wct size. If n-PA has some 
infarct.sparing properties in addition to its ability to lyse 
thrombi, then it should reduce myocardial iofarci size to a 
greater extent than placebo in a mechanical occlusion- 
repelfusion model. We stodied (7) an anesthetized canine 
mod4 of 2 h of coronary 0ccIusv~n (induced wth an atraw 
matic clamp) followed by 4 h of rcperfurion mduced by 
removing the clamp. Saline solution or n-PA was admmn- 
tered 30 min after coronary artery occlusion and the infusion 
was continued for 2 h. Infarct size as a percent of the 
iscbemic risk zone was 46% in the dogs treated wtth saline 
solution and 44% in the group treated with II-PA Ip = NS) 
(7). When infarct szc as a percent of the ixhemic risk zone 
was plotted against regional myocardial blood flow in the 
risk zone during occlusion (collateral Row). a negative 
correlation was observed as expected. That is. the iower the 
coronary collateral blood Row within the risk zone, the 
larger the percent of necrosis. This relation did not differ 
between the group treated with saline solution or n-PA. The 
decree of hcmorrhanz within tbc rcw’t”used infarcts WB\ 
&ilar in the two groups. This obser&ion suggested to us 
that n-PA was not decreasing the degree of microvascular 
damage that occurred with ischemia and reperfusion. Previ- 
ously, we had shown (8) no significant infarct-sparing effccrs 
of streptokinase in a mechanical occlusion-repcrfusian 
model. Thus, at least in our hands. no in?wt-sparing effect 
of thrombolytic agents occurs in a me&&d occlusion- 
rcperfusion canine model. Other investigators (9.101, how- 
ever, have observed this eLct. The explanalion for a 
beneficial effect of thrombolysis beyond that achieved wtth 
mechantcal reperfusion in these studies is not clear. One 
potential explanation is that distal fibrin thrombi occur even 
in a mechanical model of ischemia and reperfusion and that 
these are then lysed by therapy; however in our experience 
such fibrin thrombi arc rare (I I). Another possibility ib that 
a lytic state might lower the viscosity of blood. resulting in 
better collateral Row and improved repert’urion: however. in 
our experimental mechanical models thrombolysis reduced 
neither the no-reflow nor the low reflow phenomenon as- 
sessed by either the fluorescent hioflav’n-5 dye or regional 
myocardial blood flow mcasurcmcms with radioactive mi- 
crorpherces (1.8,. 
Implications. The study of Egashira et al. (5) has raised 
the intriguing possibility that certain thrombolytic agents 
such as n-PA may reduce myocardial infarct xe ani 
h~row vgicnal function by mechanisms other than lysis of 
pmxmnl coronwy thrqmbi. However. at the present time 
the mccbamrm whereby R-PA may have this property is not 
known. Furthermore, the finding may be model dependent. 
If thus finding IS reliably reproduced only in the thrombus 
model. then it is likelv that R-PA is lvsitx distal emboli. an 
effect of obvtous importance in clinical acute myocardial 
infarction. in which there usually is a coronary thrombur 
within the coronary artery. 
